HLRCC
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy (NCT04623502) | University of Texas Southwestern Medical Center | 2019-09-30 |
| A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer (NCT01130519) | National Cancer Institute (NCI) | 2010-05-06 |
Track HLRCC automatically
Every clearance here is in the API, with alerts when new ones post.